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Introduction. The non-medical use of prescription stimulants 
(NMUPS) has become the subject of great interest for its diffusion 
among university students, who abuse these substances to cope 
with the increasing load of academic stress. NMUPS has been 
widely investigated in the U.S. due to its increasing trend; this 
behavior, however, has also been reported in Europe. The aim of 
this cross-sectional study was to examine stimulants misuse in a 
Northern Italian geographic area, identifying possible develop-
ments of the phenomenon in Italy. 
Methods. To evaluate academic and extra-academic NMUPS 
(Methylphenidate and Amphetamines), an anonymous multiple-
choice questionnaire was administrated to a sample of Bachelor’s 
and Master’s degrees students attending a University North East 
of Italy. Data elaboration and CI 95% were performed with Excel 
software 2013. Fisher’s exact tests were performed using Graph-
Pad INSTAT software. 
Results. Data from 899 correctly completed questionnaires were 
analyzed in this study. 11.3% of students reported NMUPS, with 
an apparent greater use by students aged 18-22 years (73.5%) 
and without any statistically significant gender predominance. 
Fifty-seven point eight percent of students used stimulants at most 
five times in six months, and the most frequent academic and 
extra-academic reasons to use them were respectively to improve 
concentration while studying (51.0%) and sports performance 
(25.5%). NMUPS was higher among working students than non-
working ones (p < 0.05), suggesting a use of stimulants to cope 
with stress by the first ones. 
Conclusions. These exploratory and preliminary data suggest 
that NMUPS is quite relevant in Northern Italy, suggesting a need 
for preventive and monitoring measures, as well as future analysis 
via a longitudinal multicenter study.
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Introduction
Pharmacological “cognitive enhancement” (CE) is de-
fined as the use of any psychoactive drug by healthy 
individuals with the purpose of enhancing cognition by 
improving attention, vigilance, concentration, memory 
or mood [1, 2]. CE is also referred to as “Pharmacologi-
cal Neuroenhancement”, “Cosmetic Neurology”, “Aca-
demic Performance Enhancement”, “Academic Doping” 
or even “Brain Doping” [1, 3-8].
In this study, CE and “Brain Doping” are defined as 
the assumption of Methylphenidate (MPH) and Am-
phetamines (AMPH), either detected illegally or used 
off-label, by healthy students to improve their academic 
performances [1, 2, 9, 10, 11]. According to the litera-
ture [12-14], the terms “illicit use” and “non-medical 
use of prescription stimulants” (respectively IUPS and 
NMUPS) refer to the assumption of a psychotherapeu-
tic stimulant medication, with or without a medical pre-
scription, in larger amounts or for a period longer than 
the prescribed one. These psychoactive substances, also 
called “smart drugs”, can increase brain functions in 
people with ADHD, but whether they can push a neuro-
logically healthy individual onto a higher cognitive level 
is not yet clear [9].
University students are a population at risk for CE drugs 
misuse. These drugs are used to achieve a better academ-
ic performance or personal success. However, students 
are not aware ore deliberately ignore the fact that drug 
misuse can lead to addiction.
In the various studies conducted in the American con-
tinent, the prevalence rate of NMUPS in University 
students ranges from 8.1% (Midwestern University, 
U.S.) [12] to 27.6% (Puerto Rico) [17]. The prevalence 
of NMUPS (Methylphenidate and Amphetamines) has 
been found to range from 5% to 35% in surveys among 
young adult and adolescent populations of North Amer-
ica [18] and 25.6% and 8.3% in college students respec-
tively in an University of the North West of Pacific [19] 
and in a University in the Midwest [20]. Other studies 
in in various areas of the United States showed similar 
results [13, 18, 21, 22].
NMUPS ranges among European university students 
from 0.78% (in Germany)  [23] to 6.2% (in Switzer-
land) [24]. 
The most commonly reported reasons for NMUPS were 
to improve concentration (65.2%), studying perfor-
mances (59.8%) and alertness (47.5%) [20]. Moreover, 
NMUPS is more frequently associated with male gender 
and linked to having experience with drugs. The most 
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common reasons reported to use stimulants are “to learn 
faster” and “to finish more work in less time” [24]. Other 
motivations included “getting high” (31.0%) and experi-
mentation (29.9%)  [20]. Additional relatively common 
motivation for use is weight loss [25].
Intrapersonal risk factors associated with NMUPS are 
Caucasian ethnicity, poor school performance, diagno-
sis of ADHD, and low self-esteem; interpersonal factors 
are off-campus residence, various sports participation, 
NMUPS perception as socializing agents. In addition, 
exposure to advertisements related to prescription drugs, 
knowledge of prescribed stimulants, and positive atti-
tudes towards prescribed stimulants are environmental 
risk factors  [19]. High levels of stress are also signifi-
cantly correlated to high NMUPS as a strategy to cope 
with stress [17].
Adverse health effects associated to use or abuse of 
MPH are related to the cardiovascular system (e.g. an-
gina, tachycardia, arrhythmia), the central nervous sys-
tem (e.g. aggressiveness, agitation, confusion, head-
ache, tremors and mood swings) and the gastrointestinal 
system (abdominal pain, loss of appetite, anorexia and 
nausea)  [26]. Toxic manifestations of MPH are hyper-
thermia, euphoria, delirium, hallucinations and sei-
zures  [27]. It is interesting to note that in MPH-naive 
subjects, a toxic dose may be very close to the thera-
peutic dose when compared to patients undergoing long-
term treatment  [26]. Consumption of drugs containing 
amphetamines can cause similar side effects such as hy-
peractivity, hyperthermia, tachycardia, tachypnea, my-
driasis, tremors and seizures [28].
Given that stimulant use among students in foreign 
countries is an established factor, we conducted a cross-
sectional study to evaluate the phenomenon among stu-
dents of a University North East of Italy and its correla-
tion with academic stress.
In particular, the aim of this preliminary and exploratory 
study was to investigate the frequency of and the reasons 
for stimulants use and their effects on health.
Methods
This cross-sectional study was conducted during the 
2014-2015 academic year and involved students from 
Bachelor’s (three years of course) and Master’s (six 
years of course) degrees of a University North East of 
Italy.
Bachelor’s degrees sampled were Biomedical Labora-
tory Techniques, Cardiovascular Perfusion Techniques, 
Dental Hygiene, Imaging and Radiotherapy Techniques, 
Midwifery, Nursing, Physiotherapy, Psychiatric Reha-
bilitation Techniques, Speech and Language Therapy, 
while Master’s degrees sampled were Medicine and 
Dentistry. 
Data were collected through an anonymous multiple-
choice questionnaire administrated to students attending 
the first and the third year of Bachelor’s and Master’s 
degrees as well as the fifth year of Master’s degrees. 
Third year Physiotherapy, Dental Hygiene and Psychi-
atric Rehabilitation Techniques students were not sam-
pled because during the period of our study their degree 
courses did not take place.
The validated questionnaire assessed information about 
personal socio-demographic characteristics such as age, 
sex, course degree, occupation (working student vs. non-
working/unemployed student), nationality, Italian area 
of residence (Northern, Central-Southern). 
Moreover, this survey investigated characteristics of the 
students’ parents, such as current age, educational level 
(primary school, secondary school, high school, univer-
sity) and occupation (self-employed, employee, unem-
ployed, retiree, other). In order to detect the family’s lev-
el of education, the highest educational level achieved 
by at least one parent was considered. Levels of educa-
tion achieved were defined as “Low” for primary or sec-
ondary school or “High” for high school or university.
The final questions in the survey asked for information 
regarding the students’ university track and their use of 
stimulants (Methylphenidate and Amphetamines).
Information on stimulant use was collected in the form 
of frequency of use (never, 1-5, 6-15, ≥ 16 times) within 
the 6 months prior to administration of the survey.
Psychophysical state post-use (condition unchanged, fa-
tigue, satisfaction, guilt, depression, other) and side ef-
fects of stimulants (no side effects, insomnia, stomach 
pain, development of tics, loss of appetite, headache, 
else) were also investigated.
Some of the analysed reasons of stimulants use were re-
lated to academic field, such as improving in-classroom 
concentration, concentration while studying, exam per-
formance, mental stamina for studying, self-confidence 
while studying, better grades than peers and better 
grades overall.
A positive response for at least one of the above reasons 
constituted an indicator of stimulants use to enhance 
cognitive performance (CE).
Extra-academics reasons were investigated as well: los-
ing weight, improving social skills, driving, sports and 
working performances.
Finally, we added questions concerning whether stimu-
lant were consumed alone or in combination with alco-
hol, illegal substances, or other medical drugs.
The data from this study were collected and processed 
in compliance with the national law on privacy (Law N. 
196/2003). 
All students were over 18 years old (legal age in Italy) 
and they were assured of the confidentiality of their re-
sponses. They were adequately informed about the sur-
vey and their participation only takes place if voluntary.
To ensure a high response rate, the survey was brief, 
easy to complete (requiring less than 15 minutes) and 
administered at the beginning of a lecture. All question-
naires were immediately collected and their information 
was entered in a database.
Statistical and data analysis
The elaboration of results, the Confidence Interval 
(95%) of stimulants users, and the multiple logistic re-
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gression were calculated using Excel software 2013 and 
STATA 13.
Statistical analyses were carried out using Fisher’s ex-
act test or Chi-squared test with Yates correction, us-
ing GraphPad INSTAT software with significance of p 
<0.05. 
Bonferroni’s correction was implemented for the Chi-
squared with Yates, and Fisher’s exact test performed to 
compare the trends of stimulants use in the various years 
of the different degree courses to improve concentration 
while studying and practicing sports.
A multiple logistic regression was performed to evaluate 
the following variables as possible predictors of stimu-
lants use by students: male gender, being a Bachelor’s 
degree student, age, being a working student, coming 
from the North of Italy and parents’ high educational 
level.
The prevalence rates of the socio-demographic and aca-
demic features in the different groups examined were 
calculated differently (non-recalculated prevalence 
rates, prevalence rates calculated on the total sample and 
prevalence rates calculated on stimulants users) as re-
ported in text and tables.
Results
A total of 1107 questionnaires were administered and 
the response rate was 89.4%. Of the 990 questionnaires 
completed, 899 were properly compiled and analyzed.
Table 1 describes the distribution of the enrolled sub-
jects in the study, evaluating the total sample and sub-
groups of working (21.9 %) and non-working (75.4%) 
students in relation to stimulant use, gender, age classes, 
residence and university track attended. Only 2.0 % of 
stimulants users did not report their employment status. 
Our survey showed that 11.3% (102/899; CI 95% 9.3%-
13.6%) of all students consumed stimulants. Among 
them 2.3% and 9.0% used stimulants with and without 
a medical prescription respectively, showing that a large 
majority or users (79.4%) used stimulants without medi-
cal prescription.
Tab. I. Socio-demographic features and description of stimulants users of the total sample and of its subpopulations (working and non-
working students. (Prevalence rate).
  Total sample Non working students Working students
Variables
Pop.  
(N = 899)
Stimulants 
users  
(N = 102)
Pop. (N = 678)
Stimulants users 
(N = 69)**
Pop. (N = 197)
Stimulants users 
(N = 31)**
A (%) B (%) B (%) B (%) C (%) B (%) B (%) C (%)
Gender          
Female 68.9 (619/899) 11.0 (68/619) 75.4 (467/619) 6.8 (42/619) 61.8 (42/68) 22.1 (137/619) 3.9 (24/619) 35.3 (24/68)
Male 30.3 (272/899) 11.8 (32/272) 76.5 (208/272) 9.2 (25/272) 78.1 (25/32) 22.1 (60/272) 2.6 (7/272) 21.9 (7/32)
Non responders 0.9 (8/899) 25.0 (2/8) 37.5 (3/8) 25.0 (2/8) 100.0 (2/2) 0.0 (0/8) 0.0 (0/8) 0.0 (0/2)
Age (years)*
18-22 74.9 (673/899) 73.5 (75/102) 78.0 (529/678) 73.9 (51/69) 73.9 (51/69) 66.0 (130/197) 71.0 (22/31) 71.0 (22/31)
23-27 17.7 (159/899) 21.6 (22/102) 16.1 (109/678) 23.2 (16/69) 23.2 (16/69) 23.9 (47/197) 19.4 (6/31) 19.4 (6 /31)
≥ 28 4.8 (43/899) 2.0 (2/102) 3.8 (26/678) 0.0 (0/69) 0.0 (0/69) 8.1 (16/197) 6.5 (2/31) 6.5 (2/31)
Non responders 2.7 (24/899) 2.9 (3/102) 2.1 (14/678) 2.9 (2/69) 2.9 (2/69) 2.0 (4/197) 3.2 (1/31) 3.2 (1/31)
Residence
North 84.4 (759/899) 11.9 (90/759) 75.9 (576/759) 8.3 (63/759) 70.0 (63/90)
22.9^ 
(174/759)
3.4 (26/759) 28.9 (26/90)
Central-South 10.5 (94/899) 4.3 (4/94) 83.0^ (78/94) 4.3 (4/94) 100.0 (4/4) 12.8 (12/94) 0.0 (0/94) 0.0 (0/4)
Non responders 5.1 (46/899) 17.4 (8/46) 52.2 (24/46) 4.3 (2/46) 25.0 (2/8) 23.9 (11/46) 10.9 (5/46) 62.5 (5/8)
Courses
Medicine 23.4 (210/899) 6.7 (14/210) 83.8 (176/210) 5.7 (12/210) 85.7 (12/14) 15.7 (33/210) 6.1 (2/33) 14.3 (2/14)
Dentistry 5.9 (53/899) 7.5 (4/53) 81.1 (43/53) 3.8 (2/53) 50.0 (2/4) 13.2 (7/53) 14.3 (1/7) 25.0 (1/4)
Nursing 47.3 (425/899) 14.8 (63/425) 70.8 (301/425) 9.2 (39/425) 61.9 (39/63) 24.9 (106/425) 5.4 (23/425) 36.5 (23/ 63)
B.L.T. 5.2 (47/899) 19.1 (9/47) 85.1 (40/47) 17.0 (8/47) 88.9 (8/9) 14.9 (7/47) 2.1 (1/47) 11.1 (1/9)
S.L.T. 4.2 (38/899) 2.6 (1/38) 73.7 (28/38) 2.6 (1/38) 100.0 (1/1) 23.7 (9/38) 0.0 (0/38) 0.0 (0/1)
Midwifery 4.2 (38/899) 2.6 (1/38) 78.9 (30/38) 0.0 (0/38) 0.0 (0/1) 21.1 (8/38) 2.6 (1/38) 100.0 (1/1)
I.R.T. 3.8 (34/899) 5.9 2/34) 67.6 (23/34) 5.9 (2/34) 100.0 (2/2) 32.4 (11/34) 0.0 (0/34) 0.0 (0 /2)
Physiotherapy 3.0 (27/899) 14.8 (4/27) 63.0 (17/27) 7.4 (2/27) 50.0 (2/4) 37.0 (10/27) 7.4 (2/27) 50.0 (2/4)
C.P.T. 1.3 (12/899) 8.3 (1/12) 100.0 (12/12) 8.3 (1/12) 100.0 (1/1) 0.0 (0/12) 0.0 (0/12) 0.0 (0/1)
Dental Hygiene 1.1 (10/899) 20.0 (2/10) 60.0 (6/10) 20.0 (2/10) 100.0 (2/2) 30.0 (3/10) 0.0 (0/10) 0.0 (0/2)
P.R.T. 0.6 (5/899) 20.0 (1/5) 40.0 (2/5) 0.0 (0/5) 0.0 (0/1) 60.0 (3/5) 20.0 (1/5) 100.0 (1/1)
* In every column age is reported as non-recalculated prevalence rate; POP. = population **,^ p < 0,05 (Chi-square with Yates’ correction)
A= Non recalculated prevalence rate; B = Prevalence rate calculated on total sample; C = Prevalence rate calculated on stimulants users population
B.L.T.= Biomedical Laboratory Techniques; S.L.T.=Speech and Language Therapy; I.R.T.= Imaging and Radiotherapy Techniques; 
C.P.T.= Cardiovascular Perfusion Techniques; P.R.T.=Psychiatric Rehabilitation Techniques
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Working and non-working groups were homogeneous 
for gender composition (p > 0.05, Chi-squared with 
Yates’ correction = 0.9936).
Stimulant users appeared to be homogeneous in terms 
gender composition (11.0% women and 11.8% men, p > 
0.05, Chi-squared with Yates correction = 0.8227). Most 
of them were aged between 18 and 22 (73.5%), both in 
non-working students group (78.0%) and in working 
students (66.0%) group, and came from Northern Italy 
(11.9%).
Among working and non-working students the preva-
lence rate of stimulant use was respectively of 15.7% 
(31/197) and of 10.2% (69/678).
30.4% (31/102) of stimulants users were working stu-
dents. Among all working students the prevalence rate 
of stimulants use was 15.7% (31/197).
67.6% (69/102) of stimulants users in our sample were 
non-working students and among all non-working stu-
dents of the sample, the prevalence rate of stimulants use 
was 10.2% (69/678). 
The comparison among stimulants users between work-
ing (15.7%) and non-working (10.2%) students showed a 
statistically significant difference (p < 0.05, Chi-squared 
with Yates correction).
The highest consumptions of stimulants were detected 
in younger students. At 19 years old: 25.5% in Bach-
elor’s degrees vs. 3.9% in Master’s degrees; at 20 years 
old: 15.7% in Bachelor’s degrees vs. 2.0% in Master’s 
degrees; at 21 years old: 13.7% in Bachelor’s degrees vs. 
4.9% in Master’s degrees.
The lowest consumptions were detected at 27 years, 28 
years and 39 years old, when the stimulants users were 
1.0% in Bachelor’s degrees and 0.0% in Master’s de-
grees. This trend of reduction in stimulants use related 
to increasing age is not statistically significant when 
evaluated among students of 18-23 years and those aged 
≥ 24 years (p > 0.05, Chi-squared with Yates’ correction 
= 0.9031).
The majority of non-working students came from Cen-
tral-Southern Italy (83.0%), while working students 
came principally from Northern Italy (22.9%), show-
ing a statistically significant difference (p < 0.05, Chi-
squared with Yates’ correction).
The highest prevalence of students consuming stimu-
lants was found in Dentistry (7.5%) among Master de-
gree courses and in Dental Hygiene (20.0%) and Psychi-
atric Rehabilitation Techniques (20.0%) among Bach-
elor’s degree courses.
Among non-working students the higher prevalence of 
stimulant users was found in Medicine (83.8%), Cardio-
vascular Perfusion Techniques (100.0%) and Psychiatric 
Rehabilitation Techniques (60.0%), and among working 
students was found in Psychiatric Rehabilitation Tech-
niques (60.0%), Physiotherapy (37.0%), Imaging and 
Radiotherapy Techniques (32.4%) and Nursing (24.9%).
In each age group considered, the use of stimulants was 
significantly higher among students of Bachelor’s de-
grees than in those of Master’s degrees (p < 0.05, Chi-
squared with Yates’ correction).
On the total sample (N = 899), the prevalence rates of 
stimulants use to enhance cognitive performance with 
and without medical prescription were 1.9% vs. 6.2% 
respectively (p > 0.05, Fisher’s exact test  =  0.4167), 
while the prevalence rates of stimulants use for extra 
academic reasons with and without medical prescription 
were 0.8% and 4.6% (p > 0.05, Chi-squared with Yates’ 
correction = 0.2425).
2% of total sample had used stimulants, for medical or 
personal reasons, only before the six months surveyed 
by our study.
The socio-demographic features of the 1798 students’ 
parents are shown in Figure 1. Not every student who 
completed the questionnaire reported information on 
Fig. 1. Socio-demographic characteristics of sample’s parents. (Prevalence rate).
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both parents. The majority of them (50.2%) resulted in 
age class 51-60 years with a higher prevalence of high 
school level (46.9%) and of employment (74.3%). A 
statistically significant association between a low educa-
tion level of family and stimulants use by students was 
found (p < 0.05, Chi-squared with Yates’ correction).
Tab. II shows prevalence rates of stimulants use or mis-
use (alone or combined with other substances), academ-
ic and non-academic reasons for use, psychophysical 
state post-use and stimulants side effects referred among 
stimulants users (N = 102). 
Tab. II. Stimulants use by associations, reasons (academic and extra-academic), psychophysical state, side effects and predictors of use. (Preva-
lence rate).
Variables Prevalence rate
Associations
No (stimulants alone) 51.0% (52/102)
Alcohol 12.7% (13/102)
Other medical drugs 5.9% (6/102)
Other drugs 2.9% (3/102)
Non responders 27.5% (28/102)
Academic reasons for use 
To improve concentration while studying 51.0% (52/102)
To improve mental stamina for studying 48.0% (49/102)
To improve exams performance 42.2% (43/102)
To improve classroom concentration 28.4% (29/102)
To get better grades for themselves 16.7% (17/102)
To improve self-confidence while studying 14.7% (15/102)
To get higher grades than peers 9.8% (10/102)
Extra-academic reasons for use
To improve sports performance 25.5% (26/102)
To improve social skills (*) 18.6% (19/102)
To improve work performance 12.7% (13/102)
To lose weight 11.8% (12/102)
To improve driving performance 4.9% (5/102)
Psychophysical state post-use 
Condition unchanged 39.2% (40/102)
Fatigue 12.7% (13/102)
Satisfaction 6.9% (7/102)
Other 2.9% (3/102)
Guilt 2.0% (2/102)
Depression 1.0% (1/102)
Non responders 35.3% (36/102)
Side effects
No side effects 55.9% (57/102)
Insomnia 6.9% (7/102)
Stomach pain 5.9% (6/102)
Else 2.0% (2/102)
Development of tics 2.0% (2/102)
Loss of appetite 2.0% (2/102)
Headache 1.0% (1/102)
Non responders 24.5% (25/102)
Model for stimulant’s use predictors (Pseudo R2 = 0.0399, p < 0.05) Odds ratio (95% CI)
Male gender 1.3 (0.8-2.1), p = 0.336
Being a Bachalor’s Degree student 2.4 (1.3-4.4), p = 0.004
Student’s age 0.9 (0.9-1.0), p = 0.124
Being a working student 1.3 (0.8-2.2), p = 0.273
Coming from the Northern of Italy 3.1 (1.1-9.0), p = 0.034
Parents’ high educational level 0.6 (0.3-1.0) p = 0.059
* To improve alcohol or other substances effects, helping to socialize.
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The frequency rates of use in the previous six months 
were: 7.8% 1 to 5 times, 2.9% 6 to 15 times, 2.0% ≥ 16 
times. 
The combination of stimulants and alcohol (12.7%) was 
the most common. However, the majority of respondents 
(51.0%) used stimulants alone. 
Only a minority of subjects used stimulants combined 
with “medical drugs” (5.9%) with a frequency rate of 1 
to 5 times (4.9%) and ≥ 16 times (1.0%), or with “other 
drugs” (2.9%, all of them with a frequency rate of 6 to 
15 times). 
Among stimulants users, stimulants consumption for at 
least one academic reason (72.5% = 74/102) was high-
er than the one for at least one extra-academic motive 
(47.1% = 48/102).
The questionnaire showed that 29.4% of consumers had 
at least one health consequence resulting from stimulants 
use, such as depression, loss of appetite, headaches, ner-
vous tics development, fatigue, stomach pain, insomnia, 
and other not specified symptoms.
Table II includes the variables tested as predictors for 
stimulants use: male gender, being a Bachelor’s degree 
student, age, being a working student, being from the 
North of Italy and parents’ high educational level. Ac-
cording to multiple logistic regression, only the variables 
of being a Bachelor’s degree student (OR 2.4, p < 0.05) 
and coming from Northern Italy (O.R 3.1, p < 0.05) were 
significantly positively associated to stimulants use.
Figure 2 shows the frequency rates of reasons for stimu-
lant use (in academic and extra-academic fields) in the 
six months preceding this survey. The 57.8% of students 
used stimulants at most 5 times in 6 months and, among 
them, the most frequent reason for stimulant use was to 
improve concentration while studying (47.5%) and the 
less frequent one was to improve driving performance 
(1.7%), reflecting results detected among all stimulants 
users (considering all the frequencies of use). For each 
reason of stimulant use (academic and non-academic) 
the most recurrent frequency rate of use during the six 
previous months was 1 to 5 times. 
The most common academic reason for stimulants use 
was “to obtain an extra improve concentration while 
studying” (51.0%), while the most non-academic reason 
was “to improve sports performance” (25.5%).
Table III shows the socio-demographic characteristics 
of stimulants users who reported the higher assumption 
respectively for academic and non-academic reasons (to 
improve concentration while studying and to improve 
sports performance).
Both among stimulant users to improve studying con-
centration and sport performances, a higher prevalence 
rate was found in younger age class, residence in North 
of Italy, and in Medicine, Dentistry, Nursing, Biomedi-
cal Laboratory Techniques, Physiotherapy and Dental 
Hygiene.
Females showed a higher prevalence rate for studying 
motivation (6.1% for females vs. 4.8% for males, p > 
0.05, Chi-squared with Yates’ correction = 0.571), while 
males mostly reported consumption to obtain better re-
sults in sports (4.0% for males vs. 2.4% for females, p > 
0.05, Chi-squared with Yates’ correction = 0.268).
Figure 3 shows the stimulants consumer trends in the 
various years of the different degree courses in order to 
increase the concentration in the study and to improve 
sports performance. The prevalence rates are obtained 
from the total sample (N = 899).
Stimulants use to improve concentration while studying:
• Among Medicine students, the stimulants use in-
creased from the first academic year (2.9%) to the 
third (6.5%), and then decreased during the fifth year 
Fig. 2. Reasons for stimulants use (in academic and extra-academic fields) among stimulants users (N=102) by range of use. (Prevalence 
rate).
S. MAJORI ET AL.
E136
(1.7%), although the differences between the vari-
ous years were not statistically significant (p > 0.05, 
Fisher’s exact test).
• Among Dentistry students, the stimulants use de-
creased from the first (4.0%) to the third year (0.0%) 
and then increased up to the fifth (16.7%), without 
a statistically significant difference across years 
(p > 0.05, Fisher’s exact test).
• Among Bachelor’s degree students the stimulant ap-
pears to be higher during the first year for Dental 
hygiene (10.0%), Physiotherapy (7.4%) and Nursing 
(9.7%), whereas for Biomedical Laboratory Tech-
niques a rise in use is found during the third year 
(15.4%) without a significant difference from the 
first year (4.8%) of this degree course. There were 
no statistically significant differences between the 
various courses (p > 0.05, Fisher’s exact test), except 
between the first (9.7%) and the third (6.4%) year of 
Nursing (p < 0.05).
Stimulants use to improve sports performance: 
• Among students of Master’s degree courses, from 
the first to the fifth year it was observed a decreasing 
trend in Medicine students and an increasing trend in 
Dentistry students, without a statistically significant 
difference across years (p > 0.05, Fisher’s exact test).
• Among Bachelor degree students’ stimulants use is 
greater during or even limited to their first academic 
year. 
Overall, the difference in prevalence rates of stimulants 
use during each year of each degree course considered 
never showed a significant difference (p>0.05, Fisher’s 
exact test and Chi-squared with Yates correction, with 
Bonferroni’s correction).
Discussion 
To our knowledge, this is the first report that has at-
tempted to point out the prevalence rate of stimulants 
use among university students in the North-East of Italy.
This cross-sectional study shows that a non-negligible 
portion (11.3%) of 899 sampled university students used 
stimulants – currently and/or in the past six months – 
and that a smaller proportion (2.0%) of the total sample 
had used stimulants in their lifetime (exclusively before 
the surveyed period). 
Tab. III. Socio-demographic characteristics of stimulants users to improve concentration while studying (N=52) and sports performance 
(N  = 26). (Prevalence rate).
Variables
Stimulants users to improve  
concentration while studying (N = 52)
Stimulants users to improve sports 
performance (N = 26)
A (%) B (%) A (%) B (%)
Gender        
Female 6.1 (38/619) 55.9 (38/68) 2.4 (15/619) 22.1 (15/68)
Male 4.8 (13/272) 40.6 (13/32) 4.0 (11/272) 34.4 (11/32)
Non responders 12.5 (1/8) 50.0 (1/2) 0.0 (0/8) 0.0 (0/2)
Age (years)*        
18-22 71.2 (37/52) 71.2 (37/52) 73.1 (19/26) 73.1 (19/26)
23-27 21.2 (11/52) 21.2 (11/52) 23.1 (6/26) 23.1 (6/26)
≥ 28 1.9 (1/52) 1.9 (1/52) 3.8 (1/26) 3.8 (1/26)
Non responders 5.8 (3/52) 5.8 (3/52) 0.0 (0/26) 0.0 (0/26)
Residence        
North 6.1 (46/759) 51.1 (46/90) 3.2 (24/759) 26.7 (24/90)
Central-South 1.1 (1/94) 25.0 (1/4) 1.1 (1/94) 25.0 (1/4)
Non responders 10.9 (5/46) 62.5 (5/8) 2.2 (1/46) 12.5 (1/8)
Courses        
Medicine 3.3 (7/210) 50.0 (7/14) 2.4 (5/210) 35.7 (5/14)
Dentistry 5.7 (3/53) 75.0 (3/4) 1.9 (1/53) 25.0 (1/4)
Nursing 8.0 (34/425) 54.0 (34/63) 3.5 (15/425) 23.8 (15/63)
Biomedical Laboratory Techniques 10.6 (5/47) 55.6 (5/9) 4.3 (2/47) 22.2 (2/9)
Speech and Language Therapy 0.0 (0/38) 0.0 (0/1) 0.0 (0/38) 0.0 (0/1)
Midwifery 0.0 (0/38) 0.0 (0/1) 0.0 (0/38) 0.0 (0/1)
Imaging and Radiotherapy Techniques 0.0 (0/34) 0.0 (0 /2) 0.0 (0/34) 0.0 (0/2)
Physiotherapy 7.4 (2/27) 50.0 (2/4) 7.4 (2/27) 50.0 (2/4)
Cardiovascular Perfusion Techniques 0.0 (0/12) 0.0 (0/1) 0.0 (0/12) 0.0 (0/1)
Dental Hygiene 10.0 (1/10) 50.0 (1/2) 10.0 (1/10) 50.0 (1/2)
Psychiatric Rehabilitation Techniques 0.0 (0/5) 0.0 (0/1) 0.0 (0/5) 0.0 (0/1)
* In every column age is reported as non-recalculated prevalence rate
A= Prevalence rate calculated on total sample
 B = Prevalence rate calculated on stimulants users population
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Teter et al. conducted a survey on 4580 college students 
and they found a prevalence rate of 5.9% for illicit use 
of prescription stimulants in the year before their sur-
vey [20].
The population of stimulant users of our survey was 
homogeneous for gender composition and the majority 
(73.5%) was aged between 18 and 22, not confirming 
the trends of a larger consumption of stimulants among 
males  [13, 29-31] and older subjects  [32-34] found in 
other studies. A statistically significant difference in 
stimulants use among students of 18-23 years old and 
older ones was not found.
We were able to detect a significant correlation between 
lower family educational level and stimulants use with 
Fisher’s exact test; according to the multiple logistic 
regression, however, the family educational level was 
not significant as a predictor of stimulants use. Another 
European study  [35] suggests an association between 
higher educational family level and the consumption of 
some type of drugs (alcohol, tobacco, cannabis) but not 
with prescription stimulants. 
With regard to extra-academic benefits on NMUPS, the 
most frequent reason for stimulants use was to improve 
sports performance (25.5%). The second one was “to 
improve alcohol or other substances effects in helping to 
socialize” (18.6%) and, among all possible associations, 
the most common one was with alcohol (12.7%). More-
over, we found a prevalence rate of stimulants use to lose 
weight (11.8%) comparable to one detected in a study 
among US university students (11.1%) [19]. The use of 
stimulant drugs for dieting is reportedly also increasing 
in Asia [36].
These data are worthy of attention, suggesting an asso-
ciation between stimulants use and other harmful behav-
iors, such as alcohol abuse [37] and self-induced vomit-
ing, use of laxatives, diuretics, and other pills for weight 
loss [25].
With regard to academic reasons for stimulants use, it is 
interesting to compare our results to those of an Ameri-
can study [19], which detected a prevalence of NMUPS 
of 25.6% during college and found that 26.4% of stu-
dents engaging in NMUPS had a prescription for the 
drug. According to this data, NMUPS might be taking 
place among stimulants users with a medical prescrip-
tion (2.3%), although it was not clearly declared. More-
over, the top four reasons for NMUPS detected in the US 
survey [19] were academic-related (to improve focus, to 
improve concentration, to stay awake and to make study-
ing more enjoyable), resembling our identified primary 
reasons to improve concentration in studying (51.0%), 
mental stamina for studying (48.0%), exams perfor-
mance (42.2%) and classroom concentration (28.4%). 
Fig. 3. Prevalence rate of stimulants use for boosting concentration while studying and sports performance by year of degree courses.
* These years of courses were not surveyed; ** p < 0,05 (Fisher’s exact test)
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Overall, we detected a prevalence of NUMPS for CE of 
6.2%, which is greater than the one found by a study 
on 512 German university students (0.78%)  [23] and 
comparable to two other surveys conducted on univer-
sity students in Switzerland (6.2%) [24] and in Germany 
(5%) [28]. 
In New Zealand, the prevalence of use of NUMPS for 
CE in a population of university students is comparable 
to our results (6.6%) [38].
Our findings agree with the NMUPS for CE revealed 
by recent similar European studies [24, 33] and confirm 
that prevalence rates of stimulants use to practice CE are 
higher among American university students than Euro-
pean ones [1, 19, 23, 24, 33]. Easier access to stimulants, 
such as by using friends as a source or by simulating 
ADHD symptoms to obtain a false diagnosis  [19, 39, 
40], and an increasingly competitive and high pressure 
environment in the U.S. with fewer job opportunities 
after graduation [41] could explain the higher NMUPS 
among American students than European ones.
The use of a stimulant such as MPH, however, which 
has been available in the European Union (EU) since the 
1950s, has markedly increased in Europe over the past 
decade [42], probably as a consequence of the modifica-
tions of the European lifestyle, with an increased load 
of stress and economic difficulties. We therefore cannot 
exclude that in the future the prevalence rates of stimu-
lants use among European students will be comparable 
to those of American ones.
We found a statistically significant difference between 
stimulants use and being a working vs. a non-working 
student, probably due to the higher load of stress expe-
rienced by those who both work and study. Stress was in 
fact often associated with consumption of stimulants [17, 
39-41] among medicine students  [39], and several stud-
ies have suggested that NMUPS can be a strategy to cope 
with stress [17] and to try to reduce the negative effects of 
stress-related affective disorders [40, 41].
After calculating a multiple logistic regression, however, 
the variable of “being a working student” was not a sig-
nificant predictor for stimulants use. Very serious side 
effects related to stimulant use have been reported in the 
literature [26], and in our survey almost one third (29.4%) 
of consumers had relatively serious health consequences. 
Side effects are important not only for acute and long-
term health consequences, but also for their economic and 
social burden. Indeed, rising trends in emergency depart-
ment admissions involving non-medical use of stimulants 
and adverse reactions to stimulants highlight the growing 
impact of NMUPS on public health and, in particular, on 
the health of young adults both males and females [43].
In the literature, suicidal ideation is described as a pos-
sible consequence of consumption of medications for 
ADHD in young populations  [44, 45]; other potential 
side effects on the cardiovascular system or nervous sys-
tem have been linked to use of stimulants [28].
Stimulant use is also related to important long-term 
problems such as dependence and cognitive dysfunction. 
An abrupt cessation after periods of regular use leads to 
psychiatric withdrawal symptoms, including depression, 
anxiety and cravings [46]. Pharmacotherapies aimed at 
treating addiction to stimulants are at in the early stages 
of development and testing [46], and together with psy-
chotherapy they might lead to an increasing therapeutic 
success, improving the healthcare system. Furthermore, 
ADHD patients and relative prescriptions among school-
aged students have continuously increased [47, 48] in the 
past few years, due to the improved ability of ADHD 
diagnosis [48]. However the possibility of over diagno-
sis or of misdiagnosis, implying the prescription of un-
necessary medication or the absence of adequate ones, 
could lead to an increase in the need of medical services. 
This could cause an increase in social costs. 
An important strength of this study is the large number 
of participants surveyed. 
The present study shows some particularities in the 
population sampled: there were more women than men, 
reflecting the greater female presence in the Italian 
medical universities, and most of the surveyed people, 
because of the university location, came from the North 
of Italy. The results may therefore not be generalizable 
to university students in the rest of Italy. Moreover, col-
lecting data at a single point in time through a longitudi-
nal study would be a better design to support the study 
findings. For these reasons, it could be interesting to 
deepen the problem with further investigations, and fu-
ture researches should examine stimulants use in a larger 
sample with a multicenter study.
Our study shows that abuse of stimulants in our geo-
graphic area is of some importance, and the higher con-
sumption of stimulants among students from other coun-
tries might suggest a future increase in our country. 
For these reasons, an educational health program should 
be planned and implemented to prevent stimulant abuse 
throughout the country and across all ages. Informing peo-
ple by educating them as early as while they are attending 
elementary school (and by involving the children’s parents) 
through the local health services would raise awareness 
about the phenomenon and would hopefully reverse it.
Conclusions
Stimulants use was relatively prevalent in this popula-
tion (11.3%), with an apparent greater use by students 
aged 18-22 years (73.5%) and without any gender pre-
dominance. 57.8% of stimulants users consumed stim-
ulants five times in six months at most, and 47.5% of 
them justified such use in order to improve concentra-
tion while studying.
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